Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Braveheart Bio, Inc. (BRVE) had Debt to Capital Ratio of -0.00 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-18.60M |
|
-- |
|
-- |
|
$15.88M |
|
$-15.88M |
|
$0.89M |
|
$-14.99M |
|
$-14.99M |
|
$-14.99M |
|
$-14.99M |
|
$-14.99M |
|
$-14.99M |
|
$-15.88M |
|
$-15.88M |
|
7.40M |
|
7.40M |
|
$-2.51 |
|
$-2.51 |
|
| Balance Sheet Financials | |
$123.44M |
|
$0.02M |
|
$3.51M |
|
$126.96M |
|
$9.06M |
|
$0.20M |
|
$213.80M |
|
$222.86M |
|
$-95.91M |
|
$-95.91M |
|
$-95.91M |
|
7.54M |
|
| Cash Flow Statement Financials | |
$-22.14M |
|
$-3.03M |
|
$58.83M |
|
$89.16M |
|
$122.83M |
|
$33.67M |
|
$2.85M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.63 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-0.00 |
-0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-22.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
15.63% |
|
15.63% |
|
-11.81% |
|
15.66% |
|
$-12.73 |
|
$-2.99 |
|
$-2.99 |
|